About

Research director, DR2, HDRResearch director, DR2, HDR sept. 2019 - aujourd’hui · 4 ans 10 moisDe sept. 2019 à aujourd’hui · 4 ans 10 mois MeLIs- Institut NeuroMyoGène, Lyon, FranceMeLIs- Institut NeuroMyoGène, Lyon, France Medulloblastoma is a pediatric cancer affecting infants, childrens and teenagers. The primary tumor is located in the cerebellum. In one third of patients, a leptomeningeal metastatic dissemination is observed and the treatments to prevent it have long term sequelae for young patients. We have modelized medulloblastoma progression and dissemination in the chick embryo coupling developmental biology experimental paradigms and innovative imaging technics (clearing/lightsheet confocal microscopy). The chicken embryo recapitulates the immature environment in which this pediatric cancer develops. Our aim is to decipher the neurodevelopmental molecular mechanisms exploited by medulloblastoma cells to progress and disseminate.

Team info

This member did not provide any information about their team.

Scientific info

Research domains adhésion/interactions cellulaires
développement
différentiation
migration
neurobiologie
signalisation
Techniques bioinformatique
culture d’explants
imagerie confocale
Cell Models embryon de poulet